Add BrightSurf on Google Email

A clear view of mycobacterial infection

Researchers have found that Mycobacterium tuberculosis recruits more macrophages to granulomas despite the host's defense mechanisms, suggesting a new strategy in mycobacterial infection. The study used zebrafish embryos to visualize cell recruitment into granulomas and identified the RD1 genetic region as crucial for virulence.

SourcePLOS·JournalPLOS Biology·DateOct 25, 2004

Endangered frogs coexist with fungus once thought fatal

Researchers in Australia have discovered that frog populations of critically endangered species can persist with stable fungal infections, challenging the role of a deadly disease in their declines. The study found no evidence that survival differed between infected and uninfected frogs, suggesting coexistence rather than devastating i...

SourcePLOS·JournalPLOS Biology·DateOct 4, 2004

Biologists ID defense mechanism of leading fungal pathogen

Researchers at Rice University have discovered the genetic basis of Candida's defense mechanism against nitric oxide, a key player in slowing down yeast growth. The study identifies a specific gene that allows Candida to sense NO levels and ramp up its defenses, providing a potential target for new drug therapies.

SourceRice University·JournalEukaryotic Cell·DateJun 25, 2004

Clue to prion formation found, offers step toward treating puzzling diseases

Scientists have identified a novel step in the formation of prions, proteins that cause neurodegenerative diseases such as Creutzfeldt-Jakob disease and chronic wasting disease. By inhibiting this conversion with compounds blocking free sulfhydryl groups, researchers may be able to develop a therapeutic strategy against prion disease.

Sepsis and sepsis-related deaths are on the increase in U.S., according to Emory and CDC study

A recent study by Emory University and CDC found a significant increase in sepsis cases and deaths in the US over a 22-year period. The study suggests that factors such as antibiotic resistance, invasive procedures, and improvements in care among immunocompromised individuals are contributing to this trend.

SourceEmory University Health Sciences Center·JournalNew England Journal of Medicine·DateApr 16, 2003

Scientists develop 'super peptide' that kills Candida albicans

Researchers at Zengen developed a 'super peptide' that kills Candida albicans with high candidacidal activity, outperforming existing antimicrobial peptides. The discovery may help understand the unique mechanism of action of a-MSH peptides and unlock new treatments for fungal infections.

SourceZengen·JournalJournal of Materials Chemistry·DateFeb 20, 2003

Duke researchers identify the mechanisms by which drug combinations kill fungal infections

Researchers at Duke University Medical Center have traced cellular pathways that enhance the action of antifungal drugs used to treat fungal infections in people with compromised immune systems. Combining fluconazole with cyclosporin or FK506 was found to potently kill fungal cells, and the team elucidated the molecular targets involved.

SourceDuke University Medical Center·JournalThe EMBO Journal·DateFeb 6, 2002

Purple potato boost for organic food industry

Researchers at Newcastle University have discovered a purple potato variety that shows promise in resisting the devastating potato blight disease. The variety, grown commercially without using chemicals, could significantly impact the supply of organically-grown potatoes, improving availability and reducing costs for farmers.

Bill & Melinda Gates Foundation awards $15.1 million to treat African sleeping sickness, leishmaniasis

The Bill & Melinda Gates Foundation has awarded a $15.11 million grant to researchers developing new drugs for African sleeping sickness and leishmaniasis. The five-year project aims to create a world-class academic and scientific consortium to target these two parasitic diseases, which kill millions of people in developing nations.

Fighting Fungi

Researchers have uncovered a biological program that prevents the development of pathogenic fungi under nitrogen-poor conditions. The unfolded protein response (UPR) mediates this morphological response and can be targeted to develop new anti-fungal therapies.

SourceCold Spring Harbor Laboratory·JournalGenes & Development·DateNov 30, 2000

Recombinant yeast as an antifungal vaccine

Researchers have developed a recombinant yeast antifungal vaccine that protects mice from infection with blastomycosis, a deadly yeast infection of the lung. The vaccine uses a live attenuated strain of Blastomyces dermatitidis to stimulate an immune response against the pathogen.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateNov 28, 2000

Spraying milk on cucumbers kills mildew

Researchers have discovered that spraying milk on cucumbers can effectively kill powdery mildew, a major problem for organic farmers. The solution, which involves mixing one part cow's milk with nine parts water and spraying it on the plants twice a week, has been shown to be faster and more effective than chemical fungicides.

SourceNew Scientist·JournalThe New Scientist·DateOct 13, 1999